#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Neurofibromatosis Prophylaxis against transplant rejection Cardiac arrest Prolymphocytic leukaemia Isodicentric chromosome 15 syndrome Precursor T-lymphoblastic lymphoma/leukaemia recurrent Arrhythmia Endometrial cancer recurrent Penile cancer Haematological malignancy Neuroendocrine cell hyperplasia of infancy Osteogenesis imperfecta Pseudomyxoma peritonei Systemic scleroderma Deafness bilateral More trials…

    Learn about Rare Diseases

    Bronchopulmonary dysplasia – Diagnostics Rosai-Dorfman syndrome – Life with Disease Pulmonary fibrosis – Diagnostics Adrenocortical carcinoma – Life with Disease Mantle cell lymphoma stage IV – Treatment IgA nephropathy – Life with Disease Nephrotic syndrome Phenylketonuria – Diagnostics Haemophilia A with anti factor VIII Mucopolysaccharidosis I More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    ADMILPARANT Calcitriol ALN-961583 Amphotericin B Cannabis Sativa Flower Sym023 ASP2957 Valganciclovir [89Zr]Bms-986279 Mcla-129 MRNA-1345 Vemurafenib Flutafuranol (18F) Giroctocogene Fitelparvovec Sodium Iodide (123 I) Mercaptopurine Inotuzumab Ozogamicin Desogestrel Levocabastine Hydrochloride Tofacitinib More therapies…

    Learn about Your Condition

    Cardiac failure acute Rhabdomyosarcoma Basal cell carcinoma Kearns-Sayre syndrome Andersen-Tawil syndrome Hepatic angiosarcoma Rosai-Dorfman syndrome Left ventricular dysfunction Pharyngeal cancer stage III Intermittent claudication Hepatotoxicity HER2 protein overexpression Epileptic encephalopathy Otitis media Genital herpes simplex More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Digestive System Diseases

  • Study on the Long-Term Safety and Effectiveness of Glepaglutide for Patients with Short Bowel Syndrome

    Not recruiting

    3 1
    Investigated Diseases:
    • Short-bowel syndrome
    Investigated Drugs:
    • Glepaglutide
    Belgium France Germany The Netherlands Poland

  • Study on the Effectiveness of FOLFOX and Panitumumab for Patients with Metastatic Colorectal Cancer Without RAS Mutation

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Colorectal adenocarcinoma
    Investigated Drugs:
    • Panitumumab
    • Capecitabine
    • Fluorouracil
    Belgium France

  • Study on the Effects of Hyperbaric Oxygen Therapy for Patients with Moderate-to-Severe Ulcerative Colitis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Oxygen
    The Netherlands

  • Study of SCO-101 with FOLFIRI for Patients with Metastatic Colorectal Cancer Resistant to FOLFIRI

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Colorectal cancer metastatic
    Investigated Drugs:
    • N-[4-Bromo-2-(1H-1,2,3,4-Tetrazol-5-Yl)Phenyl]-N’-[3,5- Bis(Trifluoromethyl)Phenyl]Urea
    • Disodium Folinate
    • Fluorouracil
    Spain

  • Study on Long-Term Safety of Adalimumab for Children with Ulcerative Colitis Who Completed Previous Study

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Adalimumab
    Poland Slovakia

  • Study on the Effects of Ozanimod for Children with Moderate to Severe Crohn’s Disease Not Responding to Usual Treatments

    Not recruiting

    4 1 1 1
    Investigated Diseases:
    • Crohn’s disease
    Investigated Drugs:
    • Ozanimod
    Belgium France Germany Hungary Poland Spain
Previous Page
1 … 72 73 74 75 76 … 93
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!